APA (7th ed.) Citation

Saad, F., George, D. J., Cookson, M. S., Saltzstein, D. R., Tutrone, R., Bossi, A., . . . Shore, N. D. (2023). Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer. Cancers, 15(19), 4854. https://doi.org/10.3390/cancers15194854

Chicago Style (17th ed.) Citation

Saad, Fred, et al. "Relugolix Vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer." Cancers 15, no. 19 (2023): 4854. https://doi.org/10.3390/cancers15194854.

MLA (9th ed.) Citation

Saad, Fred, et al. "Relugolix Vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer." Cancers, vol. 15, no. 19, 2023, p. 4854, https://doi.org/10.3390/cancers15194854.